Hairy root culture is a potential alternative to conventional mammalian cell culture to produce recombinant proteins due to its ease in protein recovery, low costs and absence of potentially human pathogenic contaminants. The current study focussed to develop a new platform of a hairy root culture system from Nicotiana tabacum for the production of recombinant human EPO (rhEPO), which is regularly produced in mammalian cells. The human EPO construct was amplified with C-terminal hexahistidine tag from a cDNA of Caco-2 cells. Two versions of rhEPO clones, with or without the N-terminal calreticulin (cal) fusion sequence, were produced by cloning the amplified construct into gateway binary vector pK 7 WG2D. Following Agrobacterium rhizogenes mediated transformation of tobacco explants; integration and expression of constructs in hairy roots were confirmed by several tests at DNA, RNA and protein levels. The amount of intracellular rhEPO from hairy root cultures with cal signal peptide was measured up to 66.75 ng g -1 of total soluble protein. The presence of the ER signal peptide (cal) was essential for the secretion of rhEPO into the spent medium; no protein was detected from hairy root cultures without ER signal peptide. The addition of polyvinylpyrrolidone enhanced the stabilization of secreted rhEPO leading to a 5.6 fold increase to a maximum concentration of 185.48 pg rhEPO HR g -1 FW hairy root cultures. The rhizo-secreted rhEPO was separated by HPLC and its biological activity was confirmed by testing distinct parameters for proliferation and survival in retinal pigment epithelial cells (ARPE). In addition, the rhEPO was detected to an amount 14.8 ng g -1 of total soluble leaf protein in transgenic T 0 generation plantlets regenerated from hairy root cultures with cal signal peptide.
Introduction
Erythropoietin (EPO) is a glycoprotein hormone, which influences the production of erythrocytes through a process called erythropoiesis [1] . It is a common medicine for the treatment of PLOS ONE | https://doi.org/10.1371/journal.pone.0182367 August 11, 2017 1 / 23 a1111111111 a1111111111 a1111111111 a1111111111 a1111111111
anemia especially due to severe kidney failures [1] . It has a rapid response to all dialysis patients in the clinical trials and the patients became independent of blood transfusion [2] . It also exhibits parallel functions corresponding to erythropoiesis in non-erythropoietic tissues such as proliferation and differentiation [3] . It has additional protective functions in various cell types [4] . The major pleiotropic actions of EPO include neuroprotection in brain [5] , cardiovascular protection [6] and retinal neuroprotection [7] , which attracts the interest of scientific community. In the history of sports, EPO was used as a doping agent to improve the physiological performance in athletes of endurance sports [8] . Due to these applications, the research in synthesis and function of recombinant human erythropoietin (rhEPO) is extremely appreciated by pharmaceutical companies, research and academic institutions. Europe, North America and Asia-pacific are the major continents, which are widely engaged in the manufacture of rhEPO. Amgen Inc., Roche Diagnostics, Hospira Inc., are the key companies that actively participate in rhEPO market. RhEPO is formulated as gel, ointment, capsule or syrup and marketed by around 25 companies. The types of rhEPO that are highly promoted in the global pharmaceutical market are Epoietin (alfa, beta, gamma, omega, and delta) and darbopoietin-alfa. Production of rhEPO was successfully achieved in prokaryotic cells (Escherichia coli) [9] , eukaryotic cells such as Pichia pastoris [10] and the standard CHO mammalian cells [11] . The increasing demand for rhEPO in the pharmaceutical market are unlikely to be fulfilled with the limited potential and high cost of production from conventional mammalian cell cultures [12] . In order to overcome these limitations, plants as bioreactors may offer an alternative system for the production of pharmaceutically valuable rhEPO. The plant systems reported for the expression of rhEPO are cultured cells of tobacco [12] - [14] , tobacco plants (N. tabacum) [15] - [18] , Nicotiana benthamiana [19] , Medicago truncatula [18] , Arabidopsis [18] , [20] and the moss Physcomitrella patens [21] . The production of recombinant therapeutic proteins is favoured in tobacco plants due to their fast growth, rapid reproduction and maintenance of genetic stability [22] . The tobacco plants are a naturally biosafe non-feed crop which can be easily used for the production of plant made therapeutics by minimizing the risk of contamination in the food chain [23] .
The major advantage of plant expression systems is the high scale of consistent production of recombinant proteins and their ability to perform post-translational modification similar to mammalian systems [24] . Rhizosecretion, i.e. the secretion of proteins from roots, is an attractive new technology for the production of recombinant proteins from transgenic plants. Highly branched hairy roots, which are covered with tiny root hairs, represent an interesting plant tissue culture system for the continuous production of recombinant proteins and secondary metabolites [25] . These cultures can grow on Murashige Skoog (MS) media [26] with sugars and do not require any hormones or vitamins for their growth [27] . Root cultures can be maintained in bioreactors for a prolonged period [28] . The secretion of recombinant proteins into the culture medium of hairy root cultures attributes to the reduced cost of production due to the ease of downstream process and enhanced yield of protein recovery. The pharmaceutical proteins purified from hairy root cultures are less likely contaminated with human viral pathogens [29] .
A few examples for the expression and secretion of recombinant proteins from tobacco hairy root cultures are xylanase of the bacterium Clostridium thermocellum, human placental alkaline phosphatase (SEAP), green fluorescent protein (GFP) of the jellyfish Aequorea victoria [30] and heat inducible β-glucuronidase [31] . The transformation of plants with A. rhizogenes has attracted interest because of the ease of plantlet regeneration from the plant tissues transformed with root inducing (Ri) T-DNA. Earlier reports in Catharanthus roseus [32] and Solidago nemoralis [33] are the few examples for the regeneration of plants from hairy root cultures produced through A. rhizogenes mediated transformation. The T-DNA integration of the expression plasmid into the plant genome facilitates normal differentiation of transformed callus or roots to regenerate into whole plants [34] , [35] . This type of mechanism allows the transfer of genetic information encoded in the expression construct to the consecutive generations [36] .
Herein, we report an improved hairy root culture system of tobacco (Nicotiana tabacum) for the expression and secretion of biologically active rhEPO. Leaf explants of tobacco were transformed with A. rhizogenes containing the EPO expression constructs with or without cal signal sequence. The cal signal sequence was fused to the EPO gene to facilitate the expression and secretion of rhEPO from the hairy root cultures (rhEPO HR ). Biological activity of the rhE-PO HR secreted from hairy root cultures with cal signal peptide was determined using a retinal pigmented epithelial (ARPE) cells. Both integrity and in vitro biological efficacy of the rhE-PO HR secreted from hairy root cultures with cal signal peptide were shown to be similar to the commercially rhEPO, produced from mammalian CHO cells. Therefore, the present study report a simple hairy root culture system for the in vitro production of biologically active rhEPO HR .
Materials and methods

Cloning of EPO
Total RNA was isolated using TRIzol 1 reagent (Invitrogen) from Caco-2 cells and the cDNA was produced using AMV reverse transcriptase (Promega). The EPO gene was amplified from cDNA using the gene specific primers F1 5 0 GCCGAGCTTCCCGGGATG 3 0 and R1 5 0 GAGTGA GCTCAGGCGTCTTC 3 0 . PCR was performed with the initial denaturation at 94˚C for 5 min, followed by 35 cycles of 94˚C for 45 sec denaturation, 57˚C for 45 sec annealing, 72˚C for 1 min extension and with the final extension at 72˚C for 7 min. The amplified product was purified using Nucleospin extract columns (Macheray-Nagel). The amplicon of 0.958 kb size was cloned in pDrive cloning vector (Qiagen) and the recombinant plasmid pDrive rhEPO was introduced into E. coli strain DH5α through electroporation (Gene Pulser, Biorad). The recombinant plasmid pDrive rhEPO was sequenced with M13 forward 5 0 GTAAAACGACGGCCAG 3 0 and reverse primer 5 0 CAGGAAACAGCTATGAC 3 0 by using the DYEnamic ET Terminator Cycle Sequencing Kit (GE Healthcare) and MegaBACE™ 1000 sequencer (GE Healthcare). The resulting sequences were compared with the nucleotide sequence of EPO transcript (ENSG00000130427) from the Ensembl database in pair-wise alignment using ClustalW software. cal/rhEPO. The construct for EPO without the cal signal ( pK7 rhEPO) was generated by Gateway™ technology using primers F3 5' GGGGACAAGTTTGTACAAAAAAGCAGG CTTCGAAGGAGATAGAA CATGGGGGTGCACGAATGTCCTG 3' and R3 5' GGGACCACTTTGTACAAGAAAGCTGGGTC TCAGTGGTGGTGGTGGTGGTGTCTGTCCCCTG TCCTGCAG 3'. The sequences of "attB" site and six-histidine tag in the primers were depicted in italicized and underlined characters respectively. The "attB" sites were added according to the kit manufacturer's instructions.
Vector construction for expression of EPO
Electrotransformation of expression constructs into Agrobacterium
The expression constructs with or without cal signal sequence was transferred into A. rhizogenes (ATCC15834) through electroporation using Gene Pulser (Bio-Rad). An aliquot of the reaction mixture was incubated overnight at 28˚C in a selective Yeast Mannitol Broth (YMB) medium [38] with spectinomycin (50 mg L -1 ). Colony PCR was performed with primers (P35S 5' ACAATCCCACTATCCTTC 3' and T35S 5' TCTGGG AACTACTCACAC 3') to analyse the plasmid uptake. The positive clones were confirmed by sequencing (cloning of human EPO section) the plasmids using P35S and T35S primers (data not shown).
Agrobacterium rhizogenes-mediated transformation of N. tabacum
The transformed A. rhizogenes were grown overnight at 28˚C in YMB medium containing spectinomycin (50 mg L -1 ). The non-transformed A. rhizogenes (ATCC 15834) were grown in YMB medium containing no antibiotic and were used as a control. The cells were collected by centrifugation and were resuspended to OD 600 = 1.0 using ½ MS [26] broth. Explants (discs of 0.5-1 cm 2 ) were excised from mature leaves of N. tabacum. The explants were incubated with transformed or non-transformed A. rhizogenes at room temperature for 30 min in gentle shaking for co-infection. Then, the explants were incubated for 2-3 d in dark on solid Woody Plant Medium (WPM) [39] .
After this period of incubation, the explants infected with transformed A. rhizogenes were transferred to solid WPM containing kanamycin (50 mg L restriction endonuclease. The digested products were separated by electrophoresis in 0.8% w/v agarose. Then, the DNA in agarose gel was transferred to a Hybond-N + nylon membrane (Amersham Biosciences) through capillary transfer for overnight at room temperature. The probe (0.6 kb) was produced by PCR using F2 and R2 primers ( Fig 1A) and the conditions for PCR were explained above (cloning of human EPO section). In this analysis, DIG (Digoxigenin) labelled probe (PCR DIG Labelling kit, Roche) was used to study the integration of EPO in plant genomic DNA. Pre-hybridization of the membrane was performed at 60˚C for 2 h using 20X SSC (sodium chloride and sodium citrate) buffer. Hybridization with EPO DIG labelled probe was performed at 60˚C for 12 h. The membrane was washed with 2X SSC at room temperature. The hybridized probes were immunodetected with anti-DIG-AP (anti-DIG conjugated with alkaline phosphatase enzyme) using the substrate (CSPD) for chemiluminescent reaction. Then, the membrane was exposed to an X-ray film for 15-30 min. negative control. Total RNA was isolated using TRIzol reagent (Invitrogen). The cDNA was produced using AMV reverse transcriptase (Promega) and ImProm-II™ Reverse Transcription System (Promega). The EPO cDNA was amplified using F2 and R2 gene specific primers ( Fig  1A) . The internal control β actin gene (GenBank X63603.1) was amplified using the primers NtAct forward 5' GCTATTCAGGCTGTCCTTTCCTTGTATG 3' and NtAct reverse 5' CCGA TATCAACATCACACTTCATAATG 3'. PCR conditions for the amplification of EPO and β actin genes were the same as explained above (cloning of human EPO section).
Regeneration of T 0 plantlets
Analysis of rhEPO HR expression
Protein preparation from hairy root cultures. For the extraction of intracellular total protein, the fresh hairy root cultures (1 g) were collected and were powdered in presence of liquid nitrogen. Then it was homogenized using 1 ml of protein extraction buffer (300 mM sodium chloride, 50 mM sodium dihydrogen phosphate, 0.1% v/v Tween-20, 5 mM phenylmethyl sulfonyl fluoride, pH 8). The resulting lysate was sonicated (Bandelin Sonorex RK514) for 5 min. Then it was centrifuged to clarify the protein supernatant. The clarified proteins were used for Western blot and ELISA analysis. For the preparation of extracellular total protein, the spent medium of the hairy root clones were collected directly and were used for ELISA analysis. Then, the protein samples were affinity purified using Ni-TED columns (discussed later). The purified proteins were used for HPLC analysis and biological assays. cal/rhEPO RP was also detected in this assay. Standards ranging from 0.1 to 100 mIU rhEPO mL -1 (1 IU = 10 ng) were included in the kit. The standards and the test samples (total protein samples from hairy root cultures and leaves of regenerated plantlets) were analysed in wells pre-coated with EPO antibody. A volume of 100 μL from a 40 μg mL -1 stock solution was added to each well in order to obtain absorbance values in detectable range of concentrations for the standard EPO provided by the kit manufacturer. The samples were incubated for 2.5 h in the pre-coated wells. The wells were washed by using wash buffer (provided in the kit) to remove unbound protein in the wells. In the next step, biotinylated human erythropoietin antibody was added and was incubated for 1 h. Again, the wells were washed to remove the unbound biotinylated antibody. It is followed by the addition of HRP-streptavidin conjugate to the wells and the wells were incubated for 45 min. The wells were washed again and substrate 3,3',5,5'-tetra methyl benzidine (TMB) was added. The wells were incubated for colour development. In the next step, the stop solution (provided in the kit) was added to the wells and the absorbance was measured at 450 nm. (ACME 9000) using a Kromasil 100-5C18 column (250 x 4.6 mm length), SP930D gradient pump and UV730D detector. The isocratic separation was carried out with 150 mM phosphate buffer, pH 7.0 with a flow rate of 0.35 mL/min. The parameters were selected according to the instructions of Agilent Technologies for separating rhEPO expressed in CHO cell lines (rhE-PO CHO ). The peak for 10 ng of standard EPO (Sigma-Aldrich) was recorded at 225 nm wavelength and the peak area of the test samples were compared accordingly.
Bioactivity of recombinant rhEPO HR
Preparation of a retinal pigmented epithelial (ARPE) cells. ARPE cells (10 3 cells/well)
were grown in DMEM supplemented with 10% v/v FCS (Sigma-Aldrich). After the cells had reached 80-90% confluence, they were grown in serum-reduced medium (DMEM supplemented with 2% v/v FCS) for 24 h. It was followed by the addition of different concentrations (serial dilutions ranging from 10 ng mL -1 to 0.001 ng mL -1 ) of rhEPO HR to the cells and the cells were grown for 24 h at 37˚C in CO 2 incubator. All the samples in these assays were performed in triplicates. MTT assay. EPO activity on cell viability was measured using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide), (Sigma-Aldrich). The treated cells (as explained above) were washed with 1x PBS. 100 μL of MTT (5 mg mL -1 PBS) was added to each well and the cells were kept overnight at 37˚C in CO 2 incubator. After this incubation, 100 μL of DMSO was added to dissolve the crystals and the absorbance was measured at 570 nm using a microplate reader (Bio-Rad). The values of absorbance were plotted against different concentrations of rhEPO HR .
BrdU proliferation assay. Bromodeoxyuridine (BrdU) is an analogue to thymidine that binds to DNA of the newly proliferating cells. The BrdU proliferation assay was performed according to the instructions of manufacturer (CytoSelect™ BrdU Cell Proliferation ELISA Kit, Cell Bio labs Inc.). The cells treated with rhEPO HR were prepared as discussed above in MTT assay. 10 μL of BrdU labelling solution (diluted with growth medium) in a ratio of 1:100 was added to the treated cells in each well. Cells were kept at 37˚C for 2 hours in CO 2 incubator. After this step, 200 μL of FixDenat solution was added to each well and the cells were incubated for 30 min at 30˚C. Both the BrdU labelling solution and FixDenat solution were removed. A volume of 100 μL anti-BrdU-POD (POD-peroxidise) was added to each well and was incubated at room temperature for 90 min. After washing with wash buffer (provided in kit), 100 μL of substrate solution (provided in kit) was added to each well. The reactions were incubated at room temperature for 30 min until colour development. The absorbance was recorded without stop solution at 405 nm and was recorded with stop solution at 450 nm. The difference in the two absorbance values was considered for further calculations and was used for plotting graph.
Results and discussion
Cloning of human EPO
In order to express biologically active rhEPO HR in N. tabacum, the EPO cDNA of 0.958 kb was amplified from Caco-2 cells using F1 and R1 primers (Fig 1A) . The amplified product was cloned in a pDrive (Qiagen) cloning vector, which was used as a template for sub-cloning in plant binary expression vector pK 7 WG2D. The gene specific F2 and R2 primers were used for the production of EPO expression construct pK7 cal/rhEPO with cal signal sequence ( Fig  1A) . The gene specific F3 and R3 primers were used to produce EPO expression construct pK7 rhEPO without cal signal sequence (Fig 1A) . The expression constructs with or without cal signal sequence were constructed using Gateway technology™ (Fig 1) . This technology involves recombination events developed from Phage Lambda Integrase [40] and is commercially available as Gateway recombination cloning technology by Invitrogen. It provides an advanced, effective and reliable cloning technology as compared to the conventional cloning methodology [41] . An illustration of the T-DNA of the expression constructs with or without ( pK7 cal/ rhEPO or pK7 rhEPO respectively) is shown in Fig 1B. The fusion of cal signal with EPO directs the expressed protein to the secretory pathway of plant. The histidine tag fused to EPO facilitates single-step purification of the recombinant protein. The integration of T-DNA constructs into the plant genome was monitored by GFP expression.
Previously, the signal peptide of native human EPO was incorporated in the expression constructs for the secretion of rhEPO in tobacco plant [12] and cultured BY2 cells of tobacco [13] . In this study, the cal signal sequence was fused to the N-terminus of EPO gene sequence in the expression construct pK7 cal/rhEPO HR (Fig 1B) to direct expressed recombinant protein to the plant secretory pathway. The cal signal peptide incurred the cytoplasmic stability and ER transport of rhEPO HR expressed from the hairy root culture pK7 cal/rhEPO HR . The disulphide bridges are formed in ER that is essential for proper protein folding [42] . In this study, the transcription of EPO gene controlled by CaMV 35S promoter produced substantial amount of rhEPO HR from hairy root cultures. According to previous reports, the constitutive promoter CaMV 35S confers high level of expression of recombinant proteins by regulating the mechanism of transcription [43] .
Agrobacterium mediated transformation and growth kinetics of the hairy root cultures
In next steps, the expression constructs (Fig 1B) with or without cal signal sequence were transformed into A. rhizogenes, which were used for the initiation of hairy root cultures pK7 cal/ rhEPO HR or pK7 rhEPO HR (Fig 2A) . (Fig 2C) . No significant difference in growth rate was 
Regeneration of T 0 plantlets
The transgenic calli initiated from 15 d old hairy root culture pK7 cal/rhEPO HR were transferred to regeneration medium containing 50 mg L -1 kanamycin (Fig 3A) . As a control, the calli were initiated from hairy root culture Nt/ATCC HR and were transferred to the regeneration medium without antibiotic (Fig 3A) . The concentration of plant hormones reported as in Fig   3B) . This protocol resulted in substantial initiation of callus and shoot regeneration from the hairy root cultures (Fig 3A and 3B) . The potency to regenerate whole plants from the hairy roots determines the completion of genetic transformation process [44] . In agreement with this, we have produced regenerated T 0 plantlets pK7 cal/rhEPO RP from hairy root cultures pK7 cal/rhEPO HR (Fig 3A and 3B) . The morphology of regenerated T 0 plantlets had shown variations in growth of stems and leaves when compared to non-transformed plantlets (Fig 3B) , which is similar to the reports of Cheon et al. [20] .
GFP expression in hairy root cultures and leaves of regenerated plants (Fig 4B) .
Genomic DNA and transcript analysis of hairy root cultures
In the next steps, the hairy root cultures were investigated for genomic integration and transcription of the anticipated EPO gene via Southern blot and RT-PCR respectively. A single copy integration of T-DNA into tobacco genomic DNA was detected in Southern blot analysis for hairy root cultures pK7 cal/rhEPO HR and pK7 rhEPO HR using DIG labelled EPO probes ( Fig   5A) . According to the reports of [45] , [46] , a single copy integration resulted in high and stable expression of a transgene (EPO). The specific signal was detected at an expected size of about 10 kb for the EPO expression plasmid without cal signal sequence ( Fig 1B) and was used as a positive control. No signal was detected in the negative control hairy root culture Nt/ATCC HR .
In the following steps, RT-PCR analysis was performed for the transformed clones. As shown in Fig 5B, (Fig 5B) . Similarly, the level of mRNA was detected without any significant difference in presence or absence of signal sequence when stable antibody expression was detected only in the presence of signal sequence in tobacco plants [47] .
Western blot and ELISA analysis for the effect of PVP treatment on expression or yield of rhEPO Rhizosecretion of recombinant human erythropoietin culture system established in this study for the expression and secretion of rhEPO HR into the spent medium is highly advantageous due to its stable expression of rhEPO HR and simplified downstream process of protein purification. The yield of rhEPO HR can be enhanced by culturing the hairy root cultures in large scale fermenters by optimizing the growth parameters including the culture medium with minimal nuturients, temperature maintenance, low intensity light and gentle shaking (in case of liquid medium).
Conclusion
The current study provides a new platform for the production of rhEPO HR . 
